Chemokine Systems Link Obesity to Insulin Resistance

다국어 초록 (Multilingual Abstract)

Obesity is a state of chronic low-grade systemic inflammation. This chronic inflammation is deeply involved in insulin resistance,which is the underlying condition of type 2 diabetes and metabolic syndrome. A significant advance in our understanding of obesity-associated inflammation and insulin resistance has been recognition of the critical role of adipose tissue macrophages (ATMs). Chemokines are small proteins that direct the trafficking of immune cells to sites of inflammation. In addition, chemokines activate the production and secretion of inflammatory cytokines through specific G protein-coupled receptors. ATM accumulation through C-C motif chemokine receptor 2 and its ligand monocyte chemoattractant protein-1 is considered pivotal in the development of insulin resistance. However, chemokine systems appear to exhibit a high degree of functional redundancy.
Currently, more than 50 chemokines and 18 chemokine receptors exhibiting various physiological and pathological properties have been discovered. Therefore, additional, unidentified chemokine/chemokine receptor pathways that may play significant roles in ATM recruitment and insulin sensitivity remain to be fully identified. This review focuses on some of the latest findings on chemokine systems linking obesity to inflammation and subsequent development of insulin resistance.

참고문헌 (Reference)

1 Hansson GK, "The immune response in atherosclerosis: a double-edged sword" 6 : 508-519, 2006

2 Nahrendorf M, "The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions" 204 : 3037-3047, 2007

3 Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization" 25 : 677-686, 2004

4 Wu H, "T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity" 115 : 1029-1038, 2007

5 Wajchenberg BL, "Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome" 21 : 697-738, 2000

6 Cancello R, "Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgeryinduced weight loss" 54 : 2277-2286, 2005

7 Matsushima K, "Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line" 169 : 1485-1490, 1989

8 Yoshimura T, "Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants" 169 : 1449-1459, 1989

9 Zhang Y, "Positional cloning of the mouse obese gene and its human homologue" 372 : 425-432, 1994

10 Kamei N, "Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance" 281 : 26602-26614, 2006

11 Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue" 112 : 1796-1808, 2003

12 Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization" 117 : 175-184, 2007

13 Hotamisligil GS, "Nutrient sensing and inflammation in metabolic diseases" 8 : 923-934, 2008

14 Kirk EA, "Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]" 57 : 1254-1261, 2008

15 Auffray C, "Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior" 317 : 666-670, 2007

16 Odegaard JI, "Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance" 447 : 1116-1120, 2007

17 Kanda H, "MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity" 116 : 1494-1505, 2006

18 Swirski FK, "Ly-6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata" 117 : 195-205, 2007

19 Neels JG, "Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis" 284 : 20692-20698, 2009

20 Hotamisligil GS, "Inflammation and metabolic disorders" 444 : 860-867, 2006

21 Shoelson SE, "Inflammation and insulin resistance" 116 : 1793-1801, 2006

22 Neels JG, "Inflamed fat: what starts the fire?" 116 : 33-35, 2006

23 Nara N, "Disruption of CXC motif chemokine ligand- 14 in mice ameliorates obesity-induced insulin resistance" 282 : 30794-30803, 2007

24 Bonecchi R, "Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s" 187 : 129-134, 1998

25 Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance" 112 : 1821-1830, 2003

26 Zlotnik A, "Chemokines: a new classification system and their role in immunity" 12 : 121-127, 2000

27 Baggiolini M, "Chemokines and leukocyte traffic" 392 : 565-568, 1998

28 Gerard C, "Chemokines and disease" 2 : 108-115, 2001

29 Proudfoot AE, "Chemokine receptors: multifaceted therapeutic targets" 2 : 106-115, 2002

30 Mantovani A, "Cancer-related inflammation" 454 : 436-444, 2008

31 Chavey C, "CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance" 9 : 339-349, 2009

32 Kitade H, "CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/ M2 status" 61 : 1680-1690, 2012

33 Weisberg SP, "CCR2 modulates inflammatory and metabolic effects of high-fat feeding" 116 : 115-124, 2006

34 Huber J, "CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity" 93 : 3215-3221, 2008

35 Obstfeld AE, "C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis" 59 : 916-925, 2010

36 Siiteri PK, "Adipose tissue as a source of hormones" 45 (45): 277-282, 1987

37 Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance" 259 : 87-91, 1993

38 Kadowaki T, "Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome" 116 : 1784-1792, 2006

39 Lehr S, "Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders" 6 : 91-101, 2012

40 Inouye KE, "Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue" 56 : 2242-2250, 2007